Skip to main content

Clinical Studies

Cohort Studies and Registries

Development of Patient-Reported Outcome Measures

  • A disease-specific patient reported outcome measure for GCA to capture the symptoms and impact on health-related quality of life of the disease and its treatment within clinical trials and clinical care (Dr Jo Robson, Consultant and Senior Lecturer in Rheumatology, University of the West of England, Bristol)

Clinical Assessment

  • Headache in GCA (Dr Alexandra Sinclair, NIHR Clinician Scientist Fellow and Honorary Consultant Neurologist, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust)
  • A Bayesian statistical tool for GCA diagnosis (Dr Louis Clearkin, Consultant Ophthalmic Surgeon, Arrowe Park Hospital, Upton, Wirral, SPIRE Murrayfield Hospital, Wirral, and University of Liverpool)

Clinical Trials

  • The BIOVAS study – biologic agents in non-ANCA vasculitis, including GCA (Dr Pani Gopaluni, Research Fellow, University of Cambridge; Professor David Jayne, Professor of Clinical Autoimmunity, University of Cambridge)

 

Back to TARGET home page